Fri, Feb 21, 2025
Volume 11, Issue 3 (May-Jun 2017)
mljgoums 2017, 11(3): 6-9 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tavalla M, Sabzevari M. Seroepidemiological Study of Toxoplasma gondii in Patients with Multiple Sclerosis in Ahvaz, Southeastern Iran. mljgoums 2017; 11 (3) :6-9
URL: http://mlj.goums.ac.ir/article-1-984-en.html
URL: http://mlj.goums.ac.ir/article-1-984-en.html
1- Department of Medical Parasitology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , am.tavalla@gmail.com
2- Department of Medical Parasitology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Department of Medical Parasitology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract: (10203 Views)
ABSTRACT
Background and Objective: Toxoplasmosis is a common parasitic infection worldwide. The infection can be caused via consumption of contaminated meat and mother-to-child (congenital) transmission, causing changes in central nervous system tissue, eye irritation and sometimes death. The human form of the disease is often asymptomatic and may be accompanied with general discomfort and swelling of the lymph nodes when associated with chorioretinitis. Acute infection in immunocompromised individuals could lead to mortality. The purpose of this study was to determine the prevalence of anti-Toxoplasma gondii antibodies in serum of patients with multiple sclerosis (MS) referred to the MS Center in city of Ahvaz, southeastern Iran.
Methods: Blood samples were taken from 100 patients with MS and 100 healthy control participants. After separating the serum, presence of anti-Toxoplasma antibodies (IgG, IgM) was evaluated by enzyme-linked immunosorbent assay.
Results: Frequency of anti-Toxoplasma IgG was 38% and 21% in the patients and controls, respectively. Toxoplasma IgM antibodies were not detected in any of the study groups. Pearson correlation coefficient showed a significant association between Toxoplasma antibodies and MS.
Conclusion: Due to high prevalence of toxoplasmosis in MS patients, it is recommended to measure serum titers of the patients regularly, and placed them under antiparasitic therapy when necessary.
Keywords: Toxoplasma, Multiple sclerosis, MS, Ahvaz.
Background and Objective: Toxoplasmosis is a common parasitic infection worldwide. The infection can be caused via consumption of contaminated meat and mother-to-child (congenital) transmission, causing changes in central nervous system tissue, eye irritation and sometimes death. The human form of the disease is often asymptomatic and may be accompanied with general discomfort and swelling of the lymph nodes when associated with chorioretinitis. Acute infection in immunocompromised individuals could lead to mortality. The purpose of this study was to determine the prevalence of anti-Toxoplasma gondii antibodies in serum of patients with multiple sclerosis (MS) referred to the MS Center in city of Ahvaz, southeastern Iran.
Methods: Blood samples were taken from 100 patients with MS and 100 healthy control participants. After separating the serum, presence of anti-Toxoplasma antibodies (IgG, IgM) was evaluated by enzyme-linked immunosorbent assay.
Results: Frequency of anti-Toxoplasma IgG was 38% and 21% in the patients and controls, respectively. Toxoplasma IgM antibodies were not detected in any of the study groups. Pearson correlation coefficient showed a significant association between Toxoplasma antibodies and MS.
Conclusion: Due to high prevalence of toxoplasmosis in MS patients, it is recommended to measure serum titers of the patients regularly, and placed them under antiparasitic therapy when necessary.
Keywords: Toxoplasma, Multiple sclerosis, MS, Ahvaz.
Research Article: Original Paper |
Received: 2017/08/8 | Accepted: 2017/08/8 | Published: 2017/08/8 | ePublished: 2017/08/8
Received: 2017/08/8 | Accepted: 2017/08/8 | Published: 2017/08/8 | ePublished: 2017/08/8
References
1. Balleari E, Cutolo M, Accardo S. Adult-onset Still's disease associated to toxoplasma gondii infection. Clin Rheumatol. 1991; 10(3): 326-7. [DOI:10.1007/BF02208701]
2. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010; 6(8): 468-76. Doi: 10.1038/nrrheum.2010.86. [DOI:10.1038/nrrheum.2010.86]
3. Liesenfeld O. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis. 2002; 185 (Suppl 1): S96-101. [DOI:10.1086/338006]
4. Blank M, Asherson RA, Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol. 2004; 24(1): 12-23. [DOI:10.1023/B:JOCI.0000018058.28764.ce]
5. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006; 295(19): 2275-85. [DOI:10.1001/jama.295.19.2275]
6. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity J Autoimmun. 2010 May; 34(3):J168-77. Doi: 10.1016/j.jaut.2009.11.018. [DOI:10.1016/j.jaut.2009.11.018]
7. Charcot J. Histology de la selerose enplaques. Paris. Imprimeriel. Poupart-davyl; 1863, 554-5.
8. Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372(9648): 1502-17. DOI: http://dx.doi.org/10.1016/S0140-6736(08)61620-7. [DOI:10.1016/S0140-6736(08)61620-7]
9. Guarnaccia JB, Aslan M, O'Connor TZ, Hope M, Kazis L, Kashner CM, Booss J. Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability. J Rehabil Res Dev. 2006 Jan-Feb; 43(1):35-44. [DOI:10.1682/JRRD.2004.12.0158]
10. Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain. 2000; 123 (Pt 5): 968-74. [DOI:10.1093/brain/123.5.968]
11. Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006; 77(8): 918-26. [DOI:10.1136/jnnp.2006.090365]
12. Ruggieri M, Iannetti P, Polizzi A, Pavone L, Grimaldi LM. Italian Society of Paediatric Neurology Study Group on Childhood Multiple Sclerosis. Multiple sclerosis in children under 10 years of age. Neurol Sci. 2004 Nov; 25 Suppl 4:S326-35. [DOI:10.1007/s10072-004-0335-z]
13. Huycke LI. Multiple sclerosis: what occupational health nurses need to know. AAOHAN J. 2006; 54(11): 469-78. [DOI:10.1177/216507990605401101]
14. Talley CL. The emergence of multiple sclerosis, 1870-1950: a puzzle of historical epidemiology. Perspect Biol Med. 2005; 48(3): 383-95. [DOI:10.1353/pbm.2005.0079]
15. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006; 13(7): 700-22. [DOI:10.1111/j.1468-1331.2006.01342.x]
16. Masoodi R, Mohammadi Eisa, Nabavi SM, Ahmadi F. The effect of Orem based self-care program on physical quality of life in multiple sclerosis patients. Journal of Shahrekord University of medical science. 2008; 10 (2): 21-9. [Persian]
17. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain. 2000; 123(Pt 8): 1677-87. [DOI:10.1093/brain/123.8.1677]
18. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases Nat Rev Rheumatol. 2010; 6(8): 468-76. Doi: 10.1038/nrrheum.2010.86. Epub 2010 Jun 22. [DOI:10.1038/nrrheum.2010.86]
19. Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci 2011; 16:496-501.
20. Petrikova J, Amon Levin N, Shapira Y, Barzilia O, Ram M, Gilburd B, et al. Prevalence of Toxoplasma antibodies among patients with various autoimmune disease. Annals of the Rheumatic Disease. 2010 march 1, 2010; 69 (suppl2): A1-A76. http://dx.doi.org/10.1136/ard.2010.129577t. [DOI:10.1136/ard.2010.129577t]
21. Shaddel F, Sarvestani RG, Milani MS. Toxoplasma infection in human and dog population in Shiraz, Iran. J App Anim Res.1993; 3(2): 83-89. [DOI:10.1080/09712119.1993.9705958]
22. Razavi SM, Esnaashari HR, Gheisari HR. Seroepidemiological survey of toxoplasmosis by IFA technique in the Students of Faculty of Veterinary Medicine, University of Shiraz. Fac Vet Med Univ Tehran. 2003; 58(2): 163-167.
23. Rostami rad Sh, Jalayer I, Moayer Farid H. Toxoplasmosis antibody titer of 1,000 samples collected from different Regions of the province. Proceedings of the Third National Congress of diseases transmissible between human and animals. 1991; 235-236. [Persian]
24. Sedaght A, Ardehali SM, Sadigh M, Buxton M. the prevalence of toxoplasma infection in southern Iran. J Trop Med Hyg. 1978; 81(10): 204-7.
25. Mostafavi SN, Jalali Monfared L. Toxoplasmosis epidemiology in Iran: A systematic review. J. Isfahan Med School. 2012; 30(176): 1-15.[Persian]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.